<font color="red">Safety_3</font> <font color="red">and_1</font> <font color="red">preliminary_3</font> <font color="red">immunogenicity_4</font> <font color="red">of_1</font> <font color="red">Cuban_2</font> <font color="red">pneumococcal_2</font> <font color="red">conjugate_2</font> <font color="red">vaccine_2</font> <font color="red">candidate_1</font> in <font color="red">healthy_1</font> <font color="red">children_1</font> <font color="red">:_1</font> a randomized phase I clinical trial . 
<br>
<br> A <font color="red">new_1</font> <font color="red">heptavalent_1</font> <font color="red">conjugate_1</font> <font color="red">vaccine_1</font> <font color="red">(_1</font> <font color="red">PCV7-TT_1</font> <font color="red">)_1</font> <font color="red">is_1</font> <font color="red">under_1</font> <font color="red">development_1</font> in <font color="red">Cuba_1</font> <font color="red">._1</font> <font color="red">PCV7-TT_1</font> <font color="red">contains_1</font> <font color="red">2_1</font> <font color="red">μg_1</font> <font color="red">of_1</font> <font color="red">serotypes_1</font> <font color="red">1_1</font> <font color="red">,_1</font> <font color="red">5_1</font> <font color="red">,_1</font> <font color="red">14_1</font> <font color="red">,_1</font> <font color="red">18C_1</font> <font color="red">,_1</font> <font color="red">19F_1</font> <font color="red">,_1</font> <font color="red">23F_1</font> <font color="red">and_1</font> <font color="red">4_1</font> <font color="red">μg_1</font> <font color="red">of_1</font> <font color="red">6B_1</font> <font color="red">,_1</font> <font color="red">each_1</font> <font color="red">one_1</font> <font color="red">conjugated_1</font> <font color="red">to_1</font> <font color="red">tetanus_1</font> <font color="red">toxoid_1</font> <font color="red">(_1</font> <font color="red">TT_1</font> <font color="red">)_1</font> <font color="red">._1</font> This <font color="red">vaccine_1</font> <font color="red">was_1</font> <font color="red">designed_1</font> <font color="red">with_1</font> <font color="red">the_1</font> <font color="red">serotypes_1</font> that <font color="red">cause_1</font> <font color="red">most_1</font> <font color="red">invasive_1</font> <font color="red">pneumococcal_1</font> <font color="red">diseases_1</font> <font color="red">(_1</font> <font color="red">IPD_1</font> <font color="red">)_1</font> <font color="red">worldwide_1</font> <font color="red">._1</font> In the <font color="red">present_1</font> <font color="red">study_1</font> <font color="red">,_1</font> we <font color="red">investigated_1</font> <font color="red">the_1</font> <font color="red">safety_3</font> <font color="red">and_2</font> <font color="red">explored_2</font> <font color="red">the_1</font> <font color="red">immunogenicity_3</font> <font color="red">of_1</font> <font color="red">PCV7-TT_1</font> during a controlled , randomized and double blind clinical trial <font color="red">phase_1</font> <font color="red">I_1</font> <font color="red">in_1</font> <font color="red">4_1</font> <font color="red">-_1</font> <font color="red">5-year_1</font> <font color="red">-_1</font> <font color="red">old_1</font> <font color="red">children_1</font> <font color="red">._1</font> <font color="red">PCV7-TT_1</font> was <font color="red">well_2</font> <font color="red">tolerated_5</font> and as <font color="red">safe_4</font> as <font color="red">Synflorix_1</font> <font color="red">used_1</font> <font color="red">as_1</font> <font color="red">control_1</font> <font color="red">vaccine_1</font> <font color="red">._1</font> <font color="red">Following_1</font> <font color="red">a_1</font> <font color="red">single_1</font> <font color="red">-_1</font> <font color="red">dose_1</font> <font color="red">vaccination_1</font> <font color="red">,_1</font> all <font color="red">individual_1</font> <font color="red">serotypes_1</font> <font color="red">included_1</font> <font color="red">in_1</font> <font color="red">PCV7-TT_1</font> induced <font color="red">statistically_2</font> <font color="red">significant_2</font> <font color="red">increase_4</font> <font color="red">of_3</font> <font color="red">IgG_6</font> <font color="red">GMC_6</font> <font color="red">and_6</font> <font color="red">OPA_6</font> <font color="red">GMT_6</font> <font color="red">._6</font> These are <font color="red">the_1</font> <font color="red">first_1</font> <font color="red">clinical_2</font> <font color="red">results_2</font> <font color="red">of_1</font> <font color="red">PCV7-TT_1</font> in children and <font color="red">they_1</font> <font color="red">pave_1</font> <font color="red">the_1</font> <font color="red">way_1</font> <font color="red">toward_1</font> <font color="red">next_1</font> <font color="red">clinical_1</font> <font color="red">trials_1</font> <font color="red">in_1</font> <font color="red">children_1</font> and <font color="red">infants_1</font> <font color="red">._1</font> <font color="red">This_1</font> <font color="red">clinical_1</font> <font color="red">trial_1</font> <font color="red">was_1</font> <font color="red">published_1</font> in the <font color="red">Cuban_1</font> <font color="red">Public_1</font> <font color="red">Register_1</font> <font color="red">of_1</font> <font color="red">Clinical_1</font> <font color="red">Trials_1</font> with <font color="red">code_1</font> <font color="red">RPCEC00000173_1</font> <font color="red">._1</font>